+19.4%
AKAM vs THC
+46.1%
-26.7%
-46.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | +9.6% | -10.3% | -0.5% |
| 7D | -12.4% | +8.8% | -21.3% | -12.2% |
| 30D | -20.4% | +12.6% | -33.1% | -20.2% |
| 3M | -30.3% | +15.4% | -45.7% | -30.0% |
| 6M | -18.8% | +57.7% | -76.4% | -17.4% |
| YTD | -1.5% | +47.1% | -48.6% | +2.4% |
| 1Y | +19.4% | +40.7% | -21.3% | +24.1% |
| All | +19.4% | +46.1% | -26.7% | +24.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling